Stably Luminescent Staphylococcus aureus Clinical Strains for Use in Bioluminescent Imaging

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Plaut, Roger D ^a   Mocca, Christopher P ^a   Prabhakara, Ranjani ^a   Merkel, Tod J ^a   Stibitz, Scott ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BIOLUMINESCENCE; CONTROLLED STUDY; ELECTROPORATION; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PLASMID; SHUTTLE VECTOR; STAPHYLOCOCCUS AUREUS; STRAIN DIFFERENCE; WILD TYPE;

ANIMALS; BACTERIOPHAGES; CHROMOSOMES, BACTERIAL; ELECTROPORATION; FOUNDER EFFECT; GENE TRANSFER TECHNIQUES; INJECTIONS, INTRAVENOUS; LUMINESCENCE; LUMINESCENT MEASUREMENTS; MICE; OPERON; PHOTORHABDUS; PLASMIDS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; SURVIVAL ANALYSIS;

EID: 84874912695     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0059232     Document Type: Article

References (22)

1. Deleo FR, Otto M, Kreiswirth BN, Chambers HF, (2010) Community-associated meticillin-resistant Staphylococcus aureus. Lancet 375: 1557-1568.
2. Pribaz JR, Bernthal NM, Billi F, Cho JS, Ramos RI, et al. (2012) Mouse model of chronic post-arthroplasty infection: noninvasive in vivo bioluminescence imaging to monitor bacterial burden for long-term study. J Orthop Res 30: 335-340.
3. Francis KP, Joh D, Bellinger-Kawahara C, Hawkinson MJ, Purchio TF, et al. (2000) Monitoring bioluminescent Staphylococcus aureus infections in living mice using a novel luxABCDE construct. Infect Immun 68: 3594-3600.
4. Kadurugamuwa JL, Sin L, Albert E, Yu J, Francis K, et al. (2003) Direct continuous method for monitoring biofilm infection in a mouse model. Infect Immun 71: 882-890.
5. Steinhuber A, Landmann R, Goerke C, Wolz C, Fluckiger U, (2008) Bioluminescence imaging to study the promoter activity of hla of Staphylococcus aureus in vitro and in vivo. Int J Med Microbiol 298: 599-605.
6. Dumont AL, Nygaard TK, Watkins RL, Smith A, Kozhaya L, et al. (2011) Characterization of a new cytotoxin that contributes to Staphylococcus aureus pathogenesis. Mol Microbiol 79: 814-825.
7. Arnaud M, Chastanet A, Debarbouille M, (2004) New vector for efficient allelic replacement in naturally nontransformable, low-GC-content, gram-positive bacteria. Applied and Environmental Microbiology 70: 6887-6891.
8. Gray GS, Fitch WM, (1983) Evolution of antibiotic resistance genes: the DNA sequence of a kanamycin resistance gene from Staphylococcus aureus. Mol Biol Evol 1: 57-66.
9. Cybulski RJ Jr, Sanz P, Alem F, Stibitz S, Bull RL, et al. (2009) Four superoxide dismutases contribute to Bacillus anthracis virulence and provide spores with redundant protection from oxidative stress. Infect Immun 77: 274-285.
10. Highlander SK, Hulten KG, Qin X, Jiang H, Yerrapragada S, et al. (2007) Subtle genetic changes enhance virulence of methicillin resistant and sensitive Staphylococcus aureus. BMC Microbiology 7: 99.
11. Meighen EA, (1991) Molecular biology of bacterial bioluminescence. Microbiol Rev 55: 123-142.
12. Loving CL, Khurana T, Osorio M, Lee GM, Kelly VK, et al. (2009) Role of anthrax toxins in dissemination, disease progression, and induction of protective adaptive immunity in the mouse aerosol challenge model. Infect Immun 77: 255-265.
13. Horinouchi S, Weisblum B, (1982) Nucleotide sequence and functional map of pC194, a plasmid that specifies inducible chloramphenicol resistance. J Bacteriol 150: 815-825.
14. Bruckner R, (1997) Gene replacement in Staphylococcus carnosus and Staphylococcus xylosus. FEMS Microbiol Lett 151: 1-8.
15. Bae T, Glass EM, Schneewind O, Missiakas D, (2008) Generating a collection of insertion mutations in the Staphylococcus aureus genome using bursa aurealis. Methods Mol Biol 416: 103-116.
16. McNamara P (2008) Genetic manipulation of Staphylococcus aureus. In: Lindsay JA, editor. Staphylococcus: Molecular Genetics. Norfolk, United Kingdom: Caister Academic Press. 89-129.
17. Christie GE, Matthews AM, King DG, Lane KD, Olivarez NP, et al. (2010) The complete genomes of Staphylococcus aureus bacteriophages 80 and 80α-implications for the specificity of SaPI mobilization. Virology 407: 381-390.
18. Kreiswirth BN, Lofdahl S, Betley MJ, O'Reilly M, Schlievert PM, et al. (1983) The toxic shock syndrome exotoxin structural gene is not detectably transmitted by a prophage. Nature 305: 709-712.
19. Hunt C, Dionne M, Delorme M, Murdock D, Erdrich A, et al. (1999) Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus - Minnesota and North Dakota, 1997-1999. Jama-Journal of the American Medical Association 282: 1123-1125.
20. Baba T, Takeuchi F, Kuroda M, Yuzawa H, Aoki K-i, et al. (2002) Genome and virulence determinants of high virulence community-acquired MRSA. The Lancet 359: 1819-1827.
21. Duthie ES, Lorenz LL, (1952) Staphylococcal coagulase; mode of action and antigenicity. J Gen Microbiol 6: 95-107.
22. Baba T, Bae T, Schneewind O, Takeuchi F, Hiramatsu K, (2007) Genome sequence of Staphylococcus aureus strain Newman and comparative analysis of Staphylococcal genomes: polymorphism and evolution of two major pathogenicity islands. Journal of Bacteriology 190: 300-310.